Yelena Courchene, PA
Medical · Merrimack, NHNPI 1225380942
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 178 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 13 manufacturers reported payments, led by Salix Pharmaceuticals, A Division Of Bausch Health US, LLC at 31.7% of the total. Reporting peaked in 2024 at $1,970 and has fallen 53.1% since, to $925 in 2025. Among medical clinicians in NH with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 178 payments — averaging $18.17 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$1K
- AbbVie$930
- Valinor Pharma, LLC$454
- Collegium Pharmaceutical, Inc.$407
- Teva Pharmaceuticals USA, Inc.$116
- Pfizer$96
- plus $208 from 7 others
What the payments were for
- Food & beverage$3,235100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 65 | $1,025 |
| AbbVie | 40 | $930 |
| Valinor Pharma, LLC | 24 | $454 |
| Collegium Pharmaceutical, Inc. | 32 | $407 |
| Teva Pharmaceuticals USA, Inc. | 5 | $116 |
| Pfizer | 4 | $96 |
| Boston Scientific | 2 | $56 |
| Painteq LLC | 1 | $46 |
| Globus Medical | 1 | $35 |
| Tonix Medicines, Inc. | 1 | $24 |
| Braeburn Inc. | 1 | $19 |
| SPR Therapeutics, Inc | 1 | $16 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $12 |
How this compares
$3,235 in reported general payments places this provider in the 90th percentile of 124 medical providers in New Hampshire.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| RelistorMethylnaltrexone Bromide | 75 | $188,795 |
| BelbucaBuprenorphine Hcl | 131 | $98,368 |
| Xtampza ErOxycodone Myristate | 200 | $66,412 |
| NucyntaTapentadol Hcl | 61 | $54,293 |
| Nucynta ErTapentadol Hcl | 53 | $47,222 |
| MovantikNaloxegol Oxalate | 110 | $43,318 |
| QuliptaAtogepant | 30 | $35,086 |
| UbrelvyUbrogepant | 17 | $20,922 |
| Lidocaine | 63 | $18,669 |
| Aimovig AutoinjectorErenumab-Aooe | 24 | $18,026 |
| Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl | 229 | $14,600 |
| OxycontinOxycodone Hcl | 38 | $14,451 |
| SuboxoneBuprenorphine Hcl/Naloxone Hcl | 21 | $10,686 |
| Cyclobenzaprine Hcl ErCyclobenzaprine Hcl | 41 | $10,172 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 308 | $8,759 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Collegium Pharmaceutical, Inc.Belbuca, Xtampza Er, Nucynta, Nucynta Er | $407 | $266,295445 claims |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLCRelistor | $1,025 | $188,79575 claims |
| AbbVieQulipta, Ubrelvy, Savella | $930 | $64,18859 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 124 medical providers in New Hampshire.
Other medical in Merrimack
- Holly PelletierManchester$124K
- Kathrine CecilNashua$9K
- Alyssa DunnDerry$8K
- Kelly HochstetlerDover$8K
- Stacy FilionConcord$5K
- Jacqueline FournierConcord$5K
- Andrea BourkeLondonderry$5K
- Heather BigosDover$5K
- Dagan CloutierNashua$4K
- Rachel WhitmanPortsmouth$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.